4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0000950170-25-041546
Chief Legal Officer sold 79,146 shares at an average $12.90 ($1,021,211)
- Chief Legal Officer acquired 79,146 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara Chief Legal Officer | 2025-03-14 | Option exercise 10b5-1 | +79,146 | $5.45 | $431,346 | 79,145 | D |
| Meisner Lara Chief Legal Officer | 2025-03-14 | Sale 10b5-1 | −48,526 | $12.69 | $615,698 | 30,620 | D |
| Meisner Lara Chief Legal Officer | 2025-03-14 | Sale 10b5-1 | −30,620 | $13.24 | $405,513 | 0 | D |
| Derivatives | |||||||
| Meisner Lara Chief Legal Officer | 2025-03-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −48,720 | 107,187 | D | ||
| Meisner Lara Chief Legal Officer | 2025-03-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,246 | 67,119 | D | ||
| Open-market sales · 79,146 sh · avg $12.90 · $1,021,211 | |||||||
Loading xslF345X05/ownership.xml…